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The variable regions  1 (V-regions)  2 of immunoglobulin light  (VL) and heavy (VH) 
chains can be considered to be made up of four framework (FR) separated by three 
complementarity-determining (hypervariable [1-3, cf. 4]) regions or segments (CDR). 
This is supported by x-ray crystallographic studies  (5-8).  In the light chains,  FR1, 
FR2, FR3, and FR4 comprise residues  1-23, 35-49, 57-88, and 98-107 and CDR1, 
CDR2, and CDR3 comprise residues 24-34, 50-56, and 89-97F, respectively. In the 
heavy chains, the FR are 1-30, 36-49, 66-94, and 103-113 and the CDR 31-35B, 50- 
65, and 95-102. Length differences are found in CDR1 and CDR3 of the light chain, 
and in all three CDR  and FR3 of the heavy chain  (1-3, cf. 4).  Subgrouping of the 
light (9-12) and heavy chains (13, 14) has been based on the sequence differences and 
similarities largely found in FR1. 
In a recent study we reported that the various FR segments could be grouped into 
sets that consisted of chains with identical sequence (15). Chains that were identical 
except for an uncertainty concerning the presence or absence of the amide group, Glx 
or Asx, were accepted. Sets contained from 1-18 members, and when each V-region 
was traced from one FR segment to the next, it was found that members from one set 
in  FR1  could  be  associated  with  different  sets  in  FR2,  FR3,  and  FR4  (15).  This 
apparently independent assortment of FR segments was observed with human V~I, 
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mouse  V~,  rabbit  V,,  and  mouse  and  human  VHIII  chains.  The  hypothesis  was 
suggested  that  the  individual  FR  segments  were  products  of germ-line  minigenes 
which, together with those for the CDR, were assembled somatically to form the genes 
for the V-region (15).  A minigene is defined as a DNA segment coding for a portion 
of a complete V-region and which shows some evidence of segregation as a functional 
unit independent of the rest of the DNA coding for the V-region. 
Attempts  were  made  (16)  to  rearrange  the  individual  FR  sets  in  the  order  of 
increasing sequence differences from the set with the most members. This would be 
expected to eliminate the assortment, assuming that somatic mutation was determin- 
ing the  differences between  the  individual  FR  sets  (16),  but  it  only increased  the 
complexity of the assortment patterns in tracing the chains from one FR to the next. 
Moreover, there were a  substantial  number of amino acid substitutions that  would 
have required two base changes  (16). These findings made it unlikely that  somatic 
mutation was playing a fundamental role in the observed framework variability. 
Tonegawa et al. (17) isolated a mouse A-DNA clone, Ig 13 A, from a  12-d-old mouse 
embryo DNA which contained the nucleotide sequences coding for the V-region from 
FR 1 almost through CDR3, amino acid residues  1-96 (numbering as in reference 2), 
followed by an intervening sequence. More recently, Brack et al. (18) and Bernard et 
al. (19) described three other mouse Va2 DNA clones, Ig 99A and Ig 25A from embryo 
DNA and Ig 303A from adult myeloma H2020. The embryo clone, Ig 99)L coded for 
amino acid residues  1-95 whereas Ig 25;k contained the nucleotide sequences coding 
for amino acids 96-107, termed the J  segment, which includes all of FR4 and  two 
residues of CDR3 followed by an intervening sequence of about  1.2 Kb after which 
the nucleotides coding for the C-region began with a repetition of Glyl07. However, 
the clone from adult myeloma Ig 303A had a contiguous nucleotide sequence coding 
for the entire V-region, residues  1-107, followed by the 1.2 Kb intervening sequence, 
and the C-region nucleotides as in Ig 25A. Thus, the J  segment had been joined to the 
rest of the V-region between the 12th d of embryonic life and the Va 2 adult myeloma, 
confirming the hypothesis of somatic assembly (15)  for FR4 and that the J  segment 
is  a  minigene.  It  should  be  emphasized  that  because  only FR  sets  were  used  in 
demonstrating our original assortment  (15), it would be independent of, and would 
be seen, whether or not any CDR residues assorted with FR4. 
Recent findings by Seidman et al. (20, 21) with mouse V~ chains indicate that even 
in an adult  myeloma MOPC149,  two clones, K2 and K3, contained the nucleotide 
sequences  coding  for  amino  acid  residues  1-97  of the  light  chain  preceded  and 
followed by extensive flanking sequences. However, neither clone had  the sequence 
corresponding to the secreted myeloma protein as determined on a cDNA copy from 
the  mRNA,  differences  being  seen  in  FR  and  CDR.  The  complete  amino  acid 
sequence  of the  protein  was  not  available  and  whether  their  residues  96  and  97 
correspond to the end of CDR3  is not clear. The possibility arises that  the somatic 
joining of FR4 and the C-region to the third CDR is an essential step in synthesis of 
the intact myeloma light chain. 
Weigert et al.  (22)  have examined mouse V~21 sequences from NZB  mice, have 
included two residues, 96 and 97 of CDR3  in the J  piece, and have shown these to 
assort together with FR4. They suggest, because residue 96 is the most hypervariable 
residue in the light chains (1, 2) that this assortment could contribute to the generation 
of diversity. KABAT, WU, AND BILOFSKY  1301 
Examination by the Southern blot technic of EcoR 1 fragments of embryonic mouse 
DNA, annealed to cloned constant and variable cDNA sequences of MOPC149 and 
MOPC41,  which  belong to different subgroups,  showed that  six to eight  different 
sized EcoR 1 fragments of DNA formed hybrids with the cloned cDNA. On this basis 
it was proposed (20, 21) that multiple, closely related V-genes exist for each subgroup 
and  that  the number of V~ genes for the light chain  in the mouse genome for the 
many subgroups may be =200 or more. 
Although  there are not enough clones  (17-21)  to define the extent of J  segment 
unambiguously,  it  is  clearly  a  minigene  containing  all  of FR4.  The  one  clone, 
sequenced  Ig 25)~, appeared  to contain  the  last  two residues  of CDR3.  The other 
clones define ,J by difference and  it  always contains FR4 and  possibly one or two 
residues of CDR3; much more data are obviously needed. 
The V-region clones, for both V, and Vx, contain contiguous nucleotide sequences 
coding for FR 1 through most or all of CDR3. The question arises as to whether these 
are a  direct reflection of the germ line.  If so, it would be inferred that  all of these 
genes for light chains, excluding,J, already exist as such in the genome. This would be 
a stringent germ-line theory. On the other hand, the FR-assortment data suggest that 
the FR  and CDR  segments are separate in genome DNA and there must  be some 
mechanism of  joining FR and CDR segments. 
We propose to examine the available amino acid sequences to evaluate data bearing 
on these divergent views. 
Results 
The amino acid sequence data are given in reference 2 plus additional published 
sequences  (21-24),  and  other  sequences  which  (25,  26)  were  made  available  by 
Doctors Martin Weigert, Lee Hood, Michael Potter, Stuart Rudikoff, E. Apella, and 
Rose Mage. The FR fragments of each sequence were grouped into sets of identical 
residues (15). The earlier study included only human V~I, mouse V~, rabbit V~, and 
human  and  mouse VHIII.  The present  study adds  sets of human  V~II,  V,III,  and 
VxlI, mouse VrilII, and rabbit VH. Numerous sequences of myeloma proteins of the 
NZB strain have become available (22). 
Fig.  1 shows the assortment data with the new NZB sequences (22)  for mouse V, 
FR1  and FR2 segments together with the amino acid differences by which each set 
differs from the set with the largest number of members. Although the data are still 
limited because there are only two FR1 and two FR2 sets with multiple differences, 
sets containing single  and  multiple  members  of FR 1 are associated with the same 
FR2 set and vice versa. 
Table I summarizes data on sets of FR1  in relation to the CDR1.  Assuming each 
choice  of positions  1-96  of V-region  sequence  represents  a  germ-line  gene,  the 
minimum numbers of copies of identical FR 1 sequences that are required to account 
for  the  differences in  the  V-region  sequences  through  CDR1  are  estimated.  The 
human and rabbit data are not on inbred populations and the number of genes may 
be reduced by the existence of alleles if such are shown to exist. Because the basic 
pattern  of assortment  is  seen  within  inbred  mouse  strains,  definitive data  on  the 
numbers of copies are provided by these strains. The number of copies in the inbred 
and outbred species are comparable. 
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FR.__!  FFI2 
1 ASp  5 Thr  36 Tyr  39 Lys 
12 Ale  43 Pro  46 Leu 
MOPC321  MOPC321 
TEPC124  TEPC124 
3741  3741 
7043  7043 
7183  7183 
6308  6308 
7210  7210 
TEPC111  TEPCf11 
4039  4039 
6684  6684 
7175  7175 
7940  7940 
2485  2485 
7461  7461 
2960  2960 
MOPC70  MOPC63 
2880  AB22 
1229  9245 
7132  4050 
B32  (Anti-Ars)3 
4999  MCPC603 
2413  2154 
C101 
7769 
Asn  16 Phe 
MOPC63  MOPC70 
AB22  2880 
7063  1229 
9245  7132 
4050  B32 
4999 
7 differences  2413 
L  MCPC603  39 Asn  43 Ser 
1 
5Ala  12Thr  C101  J 
2154  ~6Val 
7769  ] 
Fic.  1.  Assortment of FR1 and FR2 in mouse V~ light chains. Each set of identical sequences is 
enclosed in a box. The positions and the amino acid residues by which it differs from the other sets, 
are listed above  the  FR1  and FR2 set with  the largest number of chains. Only the  positions at 
which differences are found are given above the other sets. 
12  of these  have  been  completely  sequenced  through  CDR1.  All  12  differ  from one 
another by one to five amino acids in CDR 1. Thus,  if each of these  12 CDR 1 exist in 
the  genome joined  to  an  FR1,  there  must  be  12  copies  of the  identical  FR1  in  the 
genome. Although  the remaining six chains have only been sequenced  through  FR 1, 
probably  their CDR1  would also differ from the others, and the estimate of 12 copies 
is clearly a minimum. The other V,I sets with multiple members also require multiple 
copies  of FR1  in  the  genome  to  account  for  the  different  CDR.  Only  two  chains, 
DAV  and  FIN  (27), both  of which  show anti-human  IgG activity,  have  an  identical 
FR 1 and  CDR 1 so that  but one copy would  be needed.  Thus,  of the 21  human  V~I 
chains sequenced through CDR1,  20 different  genes were needed on a stringent germ- 
line  theory.  Because  the  remaining  light  chains  were only  sequenced  through  FR1, 
the number could even reach 27/28. 
Table  I  gives  similar  data  for  mouse  V~  chains,  the  minimum  number  of copies 
required  being  27  of the  49 chains  sequenced  through  CDR1  or 27  of the  52 chains KABAT,  WU,  AND  BILOFSKY  1303 
TAnLE  I 
Numbers of FR1 Copies Required to Provide  for Each Unique CDRI Sequence Assuming a Stringent Germ- 
Line Theory 
Mini-  Minimum number 
FR 1  CDR 1  mum  of copies 
number  No. with 
No. of  of FR1  FRI corn-  Species and  No. of  No. se- 
amino  copies  pletely se-  set  se-  queneed  No. identi- 
qu-  corn-  cal  acid dif-  required  queneed  No. of sequences 
ferences  for  ences  pletely 
in set  found  CDR 1 
Light Chains 
Human 
V~I  18  12"  0  1-5  12} 
Vj  7  5  0  2-3 
V~I  2  2:~  0  2 
V,I  2  2  2  0 
V.I  29*  20/21  [20/29] 
VJI  7  2  0  1  2 
V,llI  9  6  0  1-4  6~ 
3  2  0  7  2f 
VxII  2  2  0  5  2 
Mouse 
V~21  25  25  4, 4, 4, 4, 2  1-7  16 / 
V,21B  5  5  2  2 
V,4  7§  4[J  0  2~4 
V,22  4¶  4  4  0 
V,10  2**  2  2  0 
V,I 1  7~::~  7  4 and 3  1 
V,20  2  2  2  0  1  J 
Rabbit 
v  19  and 
2  251  o  3  2 
3  21¶  o  1 
2  2***  0  3 
2  2~  o  5 
4  3§~  0  2, 5 
2  2[iJllJ  2  0  l J 
V,II  6  2/2  [2/6] 
V.III  12  8/8  [8/12] 
VxlI  2  2/2  [2/2] 
V,  52  27/49  [27/52] 
V,  44  14/22  [14/44] 
Heavy Chains 
Human 
VnIII 
Mouse 
VnlII 
VnV 
Rabbit Vn 
3  3¶¶I  0  3-5  3 / 
VnIII 
3  3****  0  3-5  31 
6  6:~:~:H:  6  0  1 (3)  VnlII 
4  4§§§§  4  0  l  (3) 
3  31515  3  0  1 
2  2¶¶¶¶  0  4  2  Vn 
25  6/6  [6/251 
22  2/10  [2/22] 
(6/10)  (6/22) 
9  2/2  [2/191 
Values in brackets give minimum number of copies for all members of FR 1 sets including those only 
sequenced through FRI. 
Values  in  parentheses  represent  number  of different  germ-line  genes required  based  on  entire 
sequence if available. 
* Two residues missing in CDR 1 of Amyloid VIII-B, one difference found in CDR l of those residues 
sequenced. Four  residues missing in  CDRI  of LOW,  a  cold agglutinin with anti-I  activity; one 
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TABLE I--continued 
~: Three residues missing in BEL; two differences found in CDR 1 of those residues sequenced. 
§ Six anti-ill ~  6 galactan; one anti-fl-o-GlcNAc. 
[J Two residues, 26 and 27 missing from S117. 
¶ All anti-phosphocholine. 
** All anti-,82 ~  6 fructosans. 
::l:~ All anti-/~2 ---* 1 fructosans. 
§§ K9-336 missing residue 32,  166 missing 31-34; includes anti-streptococcal group A variant carbo- 
hydrate,  anti-Micrococcus  lysodeikticus, anti-p-azophenylarsonate. K9-335 and  K9-338 are identical 
throughout entire V-region. 
H[I 3T74 anti-type III and 3322A anti-type VIII pneumococcal polysaccharide. 
¶I BS-1, BS-5 anti-type III; 2348-3 anti-type VIII pneumococcal polysaccharide. 
*** Residue 34 of KI9 missing. 
:I::H:  Anti-streptococcal group A-variant carbohydrate. 
§~ Residue 31-34 of 722369 missing. 
HU[] Residues 30 and 34 missing in K31-147. 
111 Residue 34 in GR' missing. 
**** Tur cold agglutinin with anti-PR, POM cold agglutinin with anti-IgG1 activity. 
:1::~:~:~  All anti-phosphocholine. 
§§§§ All anti-/~2 ~  1 fructosans. 
IIl[llll Residues 31 and 35 missing in K2, 33 and 35 in C22. 
1111 Both anti-pneumococcal type III polysaccharide. 
in FR I sets with multiple members. The footnotes to Table I show that some instances, 
with  identical  FR1  and  CDR1,  represent  various  myeloma  proteins  selected  for 
antibody specificity.  This would  tend  to reduce the number of copies more than  if 
there had been random selection. 
The rabbit  V~ data  in Table I  were also selected  for antibody specificity, almost 
being  antibodies  to  the  pneumococcal  type-specific  and  anti-streptococcal  group- 
specific  polysaccharides  (2,  23).  Nevertheless,  of the  22  chains  sequenced  through 
CDR1,  14 copies of FR1 were required  to account for the different GDR. 
The  same  type  of data  are  given  for  human,  mouse,  and  rabbit  VR  regions; 
sequence data are much more limited  but muhiple copies of FR1  are needed to join 
to the different CDR 1. 
Table  II examines  the  FR2  set,  residues  35-49,  which  was originally  recognized 
(15)  in  one  human,  four  mice,  and  eight  rabbit  light  chains  and  thus,  has  been 
preserved over about 80 million yr or before these three species diverged in evolution. 
With  the  newer  data  (22,  24)  the  number  of mouse  light  chains  in  this  set  has 
increased  to 20;  by tabulating  differences  in CDR1  and  CDR2 associated  with  this 
single FR2 sequence, an estimate of 10 separate copies of FR2 are required for the  14 
NZB mice and 5 separate copies for the 6 BALB/c mice based on the findings (I 7-2 I) 
that the DNA clones contain nucleotlde sequences coding for the entire sequence from 
FR1  approximately  through  CDR3.  To  code  for the  13  rabbit  sequences,  12  FR2 
copies would be needed despite the substantial selection for a few antibody specificities. 
A  second FR2 set was made up of seven mouse and four rabbit light chains. This 
FR2 set  differs  only at  position  36  from the  first  set  in  having Phe  instead  of Tyr. 
Three  copies  of the  six  mouse chains  and  two copies of the  four rabbit  chains  are 
required by the assumptions made above; Because the entire V-region of K9-335 and 
K9-338 were shown  by Huser and  Braun  (25)  to be identical,  two copies would be 
needed  for three sequences.  For human light chains, with three V,I; with two of two KABAT, WU,  AND  BILOFSKY  1305 
V,II;  and  two of two VxlI sets each  having an  identical  FR2,  three,  two and  two 
copies, respectively, would be required. 
Tables  III and  IV  list  the  numbers  of sets  of FR1  and  FR2,  and  the  sequence 
differences from the set with the largest number of members. The data in Table III 
are for human V,I sets, those in Table IV are for mouse V, sets but include human 
and rabbit sequences with identical FR2. The data show clearly that sets may differ 
one from another in from one to five amino acids. In both FRI and FR2, differences 
involving two base changes from the set with most members were seen in three and 
four instances;  one FR2 set had two base changes at two positions. The alternative 
forms of FR1 and FR2 occur in much lower frequency, as evidenced by the decreasing 
numbers of members of the other sets. The preserved FR2 set occurs in many more 
light chains than do the other alternatives. 
The x-ray crystallographic data on MCPC603  (6,  28) show FR2 to be a  loop in a 
region  of  the  molecule  away  from  the  combining  site  with  sufficient  space  to 
accommodate the various amino acid substitutions. Fig. 2 (28) shows the Fab fragment 
of MCPC603;  its  FR2  sequence  of the  light  chain  is  that  of set  1 present  in  one 
human, 20 mouse, and  13 rabbit chains  (Tables II and IV). 
Discussion 
The  data  in  Tables  I  and  II  clearly  show  that  if mouse  DNA  contains  linear 
sequences  of nucleotides,  each  coding  for a  V-region  from  residues  1 to  95-97  as 
inferred from the data of Tonegawa et al. (17-19)  and of Seidman et al. (20, 21)  e.g., 
from FR1  to about the end of CDR3,  then a  large number of copies of nucleotides 
coding for identical FR 1 and identical FR2 sets must be present in the genome. This 
number is far higher than was originally postulated, assuming a few identical FR, or 
subgroups, with a  large number of different CDR. 
This  raises  the  question,  as  first  put  forward  by Dreyer and  Bennett  (29)  with 
respect to the existence of many V-regions if each were associated in the genome with 
an identical sequence for the C-region, as to what is preserving the multiple copies of 
the  C-region  intact  over evolutionary  time.  This  led  to  the  inference,  now  clearly 
established by hybridization  (30)  and cloning (12,  17-21)  that the V- and C-regions 
were encoded  spearately,  and  that  there  is but  one  (or very few copies)  of the  C- 
region. 
This  dilemma applies even more forcefully to the present  data.  Not  only would 
identical FR1  and FR2 sets have to exist in multiple copies, but there is no apparent 
reason for them to be preserved intact over evolutionary time because in each instance, 
a large number of alternative FR 1 and FR2 sets are known. These may differ in from 
one to five amino acids. Moreover, in only 3 of the 22 positions of FR 1, excluding Cys 
23, and in only 2 of the 15 positions in FR2, have substitutions not been found. Thus, 
there is substantial capacity for variation without significantly affecting the capacity 
to  form the  proper three-dimensional  structure.  The  FR2  set  with  one human,  20 
mouse, and  13 rabbit V~ sequences has been preserved intact over a  period of about 
80  million  yr and  thus,  constitutes  a  primordial  FR  segment.  Its association  with 
different CDR1  and CDR2  in the inbred mouse leads to a  minimum estimate of 10 
copies in  14  NZB sequences and  5  copies in  6  BALB/c sequences.  Other sets have 
thus far been seen only in a few copies and most only in a single copy. In the outbred 1306  SOMATIC  ASSEMBLY  OF  THE  IMMUNOGLOBULIN  V-REGION  SEGMENTS 
TABL 
Variation in CDRI and CDR2 Sequences of Human, Mouse, and Rabbit V, Chains Ha 
Unique Sequence  of CDR1 and~or CDR2 
Residue 
number 
24 
25 
26 
27 
C  27A 
B 
D  C 
R  D 
E 
I  F 
28 
29 
30 
31 
32 
33 
34 
Human 
V~ 
IV 
LEN 
Mouse V 
21B  924321B  MOP~63 AB22 MOPC:121 TEPC12432~  T"  211)  211)  211)  211)  21E  21E  21E  2IF  2IF  211  21J  U8 
7210  6684  7175  7940  2485  4039  2960  746  MCPC603 
33 
36 
37 
F  38 
R 39 
40 
2  41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
C  52 
I) 53 
R 54 
55 
2  56 
Leu 
Ala 
Ser 
Ash 
Leu 
GIx 
Ser 
Leu  ARG  ARG ARG  ARG  ALA  ALA  THR  ALAILeu 
Ala  Ala  Ala  Ala  Ala  Ala  Ala  Ala  Ala  I Ala 
Ser  Ser  Ser  Ser  Ser  Ser  Ser  Ser  Set  [ Ser 
Asn  Asn  Asn  Asn  Asn  Asn  Asn  Asn  Asn  ] Asn 
l~u  1~o  =~u  i~u  i~u  i~.  =~u  X~u  i~u Its" 
Glu  Glu  GIx  Glu  Glu  Glu  Glu  Glu  I Glu  Glu 
Ser  Ser  Ser  Ser  Ser  Ser  Set  Set  Ser  Ser 
No. of copies of FR2 needed/total  sequences 
I/l 
I.eu 
Ala 
Ser 
Ash 
Leu 
Glu 
Set 
10/14 NZB 5/6 BALB/c 
3368  BS- I  BS-5 
Gin 
~la  Ala  Ala 
ier  Set  [ Ser 
[ 
3LU  G n  Gin 
Ser 
lie 
TYR 
Set 
Ash 
Leu 
Ala 
All FR2 sequences identical to Set I 
l,eu 
Ala 
Ser 
Ash 
Leu 
Glu 
Set 
IJzu  Leu  Izru  Val  GLY ] ARG] Lys  Lys 
Ala  AI~,  Al.  IAI,. IAI.  IAI.  I,',l.  I,,,la 
I  Se,"  Z  I °r 
SER  SER  Asn  INS IThr 
Leu  I,eu  I,eu  VAL  ARG 1  I,eu  I,eu  l,cu 
Glu  Glu  TYR  Glu  Glu  Ala  Ala  GLU 
Ser  Set  Set  Ser  Scr  Set  Set  Set 
___ Deletion, chain continues. 
-  Residue not  identified. 
Residues in capitals differ from most frequently occurring residue or residues within a  species or subgroup. 
•  Anti-type III pneumococcal  polysaccharide. 
•  Anti-streptococcal group A  variant carbohydrate. 
×  Anti-Micrococcus lysodeikticus. 
[] Anti-type II pneumococcal  polysaccharide. 
•  Anti-phosphocholine. 
*  FR2  of MIL  must be identical to FR2  of NIM  or of FR depending  on whether  it has GLN  or GLU  at position 42.  In either, KABAT,  WU,  AND  BILOFSKY 
E  II 
ving a Given FR2 Sequence: Estimation of Numbers of FR2 Copies Required  for Each 
Assuming a Stringent Germ-Line Theo(y 
3547 
Gin 
Ala 
Ser 
GLU 
ASP 
lie 
SER 
ALA 
Ash 
|,eu 
Ala 
Rabbit V~  Mome V~  Rabbit V~ 
L  L L  •  •  Kg-|  K30-  x  [~--  T  ~-'  .....  21A  21A  2  70 
~.48~.~O 335-{  267  120  K-2  4422  [[] ill [[]436 [[]4 92  2~)  22-'9  7 32  S{2  2 A  24t3  9-338 213  t67  ROY  AU  KA 
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Human 
V~II  [Vill 
MIL* 1  NIM or FIR  BOH  BUR 
Arg ] Arg  ]Arg / Ala / ILE 
so, I  Ser  Ser l  Gly I  ~l~ 
Set  I Set  Ser  / Thr / Thr 
Ser 
Set 
ASN 
Val 
Gly 
ASP 
TYR 
I,YS 
Tyr 
Val 
Set 
GIx 
GIx 
All FR2 sequences  identical  to Set 2 
A'Xl'Ys  XkC ASq  ,ys 
sot  Set  ~r|Se,  ISerlS~r  /Ser ISorl 
AS~  Vhr  Th, I Th~  I~,1 Vhr/ ASN[ AS 
Leu  1,eu  LeulLeu  Leu  I Leu  Leu  Ix 
Ala  Ala  I AlalAla  Ala|  Ala  Ala  Ala I 
Ser  Ser  I Serl Ser  [Ser|  Ser  Ser  Set[ 
12/13 
Ala  Ala  Ala  Ala  Gly  Lys  Lys 
Ala  Ala  Ala  Ala  Ala  Ala  IAla 
Ser  ISer  Ser  Ser  Ser  Ser  TSe~r 
Asn  Asn  Asn  Asn  Ash  Thr 
Gin  Gin  Gin  Gin  ARG  l,eu  Leu 
GIy  Gly  Gly  Gly  Gly  Ala  Ala 
Ser  Ser  Ser  Ser  Ser  Ser  Ser 
3/6  2/3  313  212 
GLU 
Val 
Ser 
Ser 
Arg 
Pro 
Set 
212 
case CDR1 and CDR2 necessitate two copies. 1308  SOMATIC ASSEMBLY OF THE  IMMUNOGLOBULIN  V-REGION SEGMENTS 
TABLE III 
FR1 Sets in Human Vd Chains and Numbers of Chains in Each Set 
No. in set 
Residue number 
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23 
Asp  Ile  Gin  Met  Thr  Gin  Set  Pro  Ser  Ser  Leu  Set  Ala  Ser  Val  Gly  Asp  Arg  Val  rhr  Ile  Thr  Cys 
lie 
Set 
lie  Leu 
Leu 
Val 
Thr 
Ala 
Thr  Val  Ala 
~,la 
Ala  [le 
Pro  Ser 
Glx 
Thr 
Leu  Phe 
Leu  I Thl 
I  Val 
Val  Phe  Val 
lie  Met  Val 
Val 
Thr  Val* 
Val 
]'hr 
Val  Phe 
Leu  Arg 
Val*  Ser  Pro  Leu 
Residues are identical  to those in the top sequence except for substitutions listed. 
* Two base changes. 
Leu  Leu* 
Phe 
rabbit,  12  copies  would  be  required  for the  13  sequences  if none of these represent 
alleles.  At  the present,  there  is  no basis  for attributing  the various copies  to alleles 
even in outbred animals. 
Huser  and  Braun  (25)  have  found  a  single  rabbit  that  makes  antibody  to  the 
streptococcal group A  variant carbohydrate with different FR1  and FR2. This rabbit 
has an identical CDR2; CDR1  differed only by a Gin Glu substitution at position 27. 
Moreover, different rabbits making antibody to the same antigen may have the same 
or different FR 1 and FR2 sets. The existence  in several species of identical  FR2 sets 
which differ substantially  in CDR1  and CDR2  suggests  that  the stability  of FR2  is 
not  maintained  by  selective  pressure  for  certain  antibody  specificities.  The  X-ray 
crystallographic  data  which support  a  stable  FR,  upon which  variation  in CDR  is 
responsible  for  specificity  differences,  also  imply  that  the  CDR  do  not  determine 
selection or maintenance of a given FR2 set. All of these favor independent assortment 
of FR2  sets.  Valbuena  et  al.  (31)  have shown by  saturation  hybridization  analysis 
that  there  are  no  more  than  four to six  germ-line  genes  for V-region  sequences  of 
V~21.  This number is substantially below that calculated in Table II as a  minimum 
value for the V~21  proteins having the preserved FR2 set. These data are consistent 
with the minigene concept. 
Thus, the data in Tables I to IV require  (a) many copies of genes for some FR 1 or 
FR2 sets with no understanding of how they are maintained intact over evolutionary 
time,  or (b)  that  in the genome, the V-region  is made up of minigenes  for each FR 
and by inference for each CDR segment, that  these be present  in only one or a  few KABAT, WU, AND  BILOFSKY  1309 
TABLE IV 
FR2 Sets in Mouse and Rabbit  V. Chains and Number of Chains in Each Set Including Those Found in Human 
and Rabbit  V. 
Set  I No. in set 
I  IH, 20M 
13R 
2  6M 
4R 
3  IM 
4  IM 
5  IM 
6  IM 
7  IM 
8  IM 
9  IM 
I0  3M 
11  IM 
12  IM 
13  4M 
Residue 
Members  of set 
35  36  37  38  39  40  41  42  43  44  45  46  47  48  49 
TRP  TYR  GLN  GLN  LYS  PRO  GLY  GLN  PRO  PRO  LYS  LEU  LEU  ILE  TYR  See Table II 
PHE  See Table I1 
ILEU* 
I  pHE 
LEU 
SER 
ASN  SER 
GLU  SER 
--  ILE 
LYS  ALA 
ASP  GLY*  THR  VAL* 
PHE  LEU  ARG  SER  GLN 
SER  THR*  SER 
MPCI I (V,19) 
VAL  PHE  7769 (V,2 IE) 
LYS*  2154 (V~21H) 
CBIOI  (V~21  E) 
MOPC21 (V,15) 
ARG  MOPC41  (V,9 
(five  residue'. 
missing) 
MOPC460  (V~l: 
(eight  residue: 
missing) 
UPC61,  EPel~ 
(V,I I);  ABPC4] 
(V~) 
MOPCI73 (V, 10) 
SER  MOPC 167 (V~24) 
PRO  TRP  XRPC44, 
XRPC24, 
TEPC 109,  J53.  C 
(V,4) 
VAL  3374:~ 
GLY  4135§ 
--  3T70~  (four  resi 
dues missing) 
ALA  271711 
GLY  LEU  XP-II[ 
ARG  3315¶ 
VAL  4153 I§ 
GLY*  AHS0-5 
1  IR 
2  IR 
3  IR 
4  IR 
5  IR 
6  IR  PHE 
7  IR 
8  1R  PHE 
ALA 
ARG 
* Two base changes.  Amino acids listed in mouse sets 2-12 and rabbit sets  I-7 are those differing from set  I. 
]1 Anti-p-azobenzoate 
§ Anti-streptococcal  group C  carbohydrate. 
¶ Anti-type  VIII pneumococcal  polysaccharide. 
Anti-type  llI pneumococcal  polysaccbaride. 
Residues  are identical  to thcse in the top sequence  except  for substitutions  listed. 
copies in the germ line, and that they are assembled somatically as we have previously 
proposed  (15)  and as has since been shown unequivocally for the J  segment  (17-19) 
which includes all of FR4.  Indeed, if many copies of genes coding for the preserved 
FR2  set  were  found already  assembled,  the explanation  of why they are  preserved 
intact, of their stabilization in evolution, and of the variation in the numbers of copies 
for each of the alternative FR2 sets will have to be at a level other than that of protein 
structure, probably in the genes themselves. 
It will obviously be of primary importance to reconcile the cloning and the sequence 
data for further understanding of the genetics of the generation of antibody diversity. 
By using mRNA or eDNA from one species having an FR2 present in several species 
or by  using  a  synthetic  DNA  stretch  from  FR2  made  to  correspond  to  an  actual 
nucleotide sequence determined by cloning (17-21, 2) one should be able to count the 
numbers of copies of FR2.  If this were done in sperm  DNA as well as in embryonic 
and adult myeloma  DNA,  some resolution of the dilemma  might  emerge.  It should 1310  SOMATIC ASSEMBLY OF THE IMMUNOGLOBULIN V-REGION SEGMENTS 
FtG.  2.  Computer  drawing of the  a-carbon  skeleton of the  Fab  fragment of MCPC603. The 
preserved FR2 loop of the L-chain residues 35-49 is indicated. Its location is such as to permit 
substitutions of side chains without necessarily changing the remaining structure. Multiple substi- 
tutions have been found at all positions except 35 and 38. Modified from reference 28. 
also be possible to perform studies in families of inbred mice immunized with various 
antigens to determine whether assortment can be demonstrated in various generations. 
The  minigene  hypothesis could  account completely  for the  amino  acid sequence 
data  and  would  substantially  reduce  the  amount  of genetic  material  required  for 
generating antibody diversity.  For example,  if each individual  had  10 FR1,  10 FR2, 
and  10 FR3 sets,  the hypothesis that  they were already assembled  in the  germ  line 
would necessitate  103 genes just  for the three  FR alone;  indeed,  10 sets for each is a 
very low number  (Tables  III and IV). It would also relegate  somatic mutation  to a 
trivial  role and to the extent  that  it occurred in the FR it would appear to increase 
the number of minigene sets.  It should be noted also that  hypotheses  (17-21)  based 
on sequencing clones also ascribe a  minor role to somatic mutation  as does a  recent 
statistical examination of variability from the view point of population genetics (32). 
The latter analysis was considered to apply to the CDR as well as to the FR.  It is of 
interest that Capra noted the low frequency of subgroup specific and of phylogeneti- 
cally associated  residues  in the last  40 residues of the VH region as compared to the 
first 40 residues, and suggested that these two segments might be under the control of 
separate genes (33). 
Weigert et al.  (22)  have proposed that in the mouse V, 21  subgroups two residues 
of CDR3, in addition  to FR4, are included in the J  segment and diversity could be 
generated  in  this  manner.  They  demonstrated  independent  assortment  of this  ex- 
tended J  segment. Because our original data  (15)  assorted only FR segments and did 
not include any CDR residues, the assortment would be independent of and would be 
seen whether or not any CDR residues were included together with FR4. As a  result, 
the two sets of data (15, 22) are consistent. As mentioned earlier, the DNA clones that KABAT, WU, AND BILOFSKY  1311 
have been isolated (17-19), show that one and two residues in CDR3 may be included 
in the J  segment of mouse Vx clones. The two V~ clones (20, 21) have been tabulated 
as terminating exactly at the end of CDR3. Thus, there is some uncertainty as to how 
many nucleotides coding for amino acids of CDR3 in addition to those for FR4 are 
present in various J  segments. Resolution of this question will require sequencing of 
additional J  containing clones.  Whether  the  assumption  of Weigert  et  al.  (22)  is 
justified  will  only  become  clear  when  such  clones  are  available  and  when  the 
mechanism  of elimination  of the  intervening  sequence  between  CDR3  and  J  is 
established. 
Summary 
Two sets of apparently conflicting data on the genes coding for the variable region 
are  being  accumulated.  One  suggests  that  the  sets  of nucleotides  coding  for  the 
framework segments of immunoglobulin light and heavy (VL and VH) chains assort 
independently and  are  therefore germ-line minigenes  which,  together with  sets  of 
nucleotides coding for the complementarity-determining regions (CDR) or segments 
assemble to form complete variable (V)-region genes (15, 16, 33). The other, based on 
the findings with clones from 12-d-old embryo and adult mouse coding for V-regions, 
infer  that  the  first  three  frameworks  and  the  three  complementarity-determining 
segments  are  already assembled  as  germ-line V-genes  (17-21).  It  is  now  generally 
accepted that the J  segment, which in the one instance sequenced (2 I) is made up of 
nucleotides coding for framework (FR)4 plus two residues of CDR3,  is a  minigene. 
An examination of sequences of human, mouse, and rabbit V-regions, assuming the 
latter hypothesis, indicates that individual framework sets would have to be present 
in  many copies. The FR2  segment  found in  one human,  20  mice, and  13  rabbits 
would have to be present in at least  10/14 copies in the NZB, and 5/6 in the BALB/ 
c mouse, and  12/13 in the rabbit. The X-ray crystallographic data show this region 
to be a  loop, projecting out  from the V-domain, capable of accommodating many 
substitutions  and  12  and  8  alternative sequences  for this  FR2  segment  have been 
found  in  mouse  and  rabbit  V,  chains  with  substitutions  possible  at  13  of the  15 
positions. These alternative sequences occur much less frequently than the preserved 
FR2 segment. Thus, there is no basis in the protein structure to account for evolu- 
tionary stability of this FR2 segment if it occurs in so many copies in germ-line genes 
coding for residues  1-96, but its stability is easily explained if it were coded for by a 
separate germ-line minigene present as a single copy; the alternative forms could then 
have arisen by duplication and mutation of this minigene. Somatic assembly of the 
minigene segments for the three framework and three complementarity-determining 
segments during differentiation would  account completely for our assortment  data 
from which FR4 was inferred to be a minigene 
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